Results 121 to 130 of about 838,128 (221)

New Delhi metallo-β-lactamase-producing Acinetobacter isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome

, 2019
Asmaa M Elbrolosy,1 Azza Z Labeeb,1 Dina M Hassan2 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt; 2Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt ...
Elbrolosy AM, Hassan DM, Labeeb AZ
core  

Assessing the Synergistic Potential of Ceftazidime-avibactam and Aztreonam against Metallo-beta-lactamase Producing Enterobacterales by Disc Elution and Disc E Strip - Synergy Method. [PDF]

Ann Afr Med
Linsy KMA, Thomas AR, Srinivasan N, Bhat S, Bhat A.   +4 more
europepmc   +1 more source

Structure-activity relationship of captopril derivatives as New Delhi metallo beta-lactamase 1 inhibitors. [PDF]

ADMET DMPK
Jarrar I.
europepmc   +1 more source

Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review

Some antibiotics that are frequently employed are β-lactams. In light of the hydrolytic process of β-lactamase, found in Gram-negative bacteria, inhibitors of β-lactamase (BLIs) have been produced.
Noor Fatima, Nasir Rasool, Bushra Parveen, Aqsa Kanwal, Shehla Khalid, Muhammad Imran, Codrut Ioan Ciurea, Marius Irimie   +7 more
core   +1 more source

Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica. [PDF]

J Antimicrob Chemother
Findlay J, Shaw JM, Nordmann P, Hinchliffe P, Laffer EB, Born Y, Seth-Smith HMB, Egli A, Pfennigwerth N, Spencer J, Poirel L.   +10 more
europepmc   +1 more source

The New Delhi Metallo-Beta-Lactamases: Their origins and implication for the intensivist

Journal of Global Infectious Diseases, 2011
Binila Chacko, John Victor Peter, Veeraraghavan Balaji   +2 more
openaire   +3 more sources

Combating New Delhi metallo-beta-lactamase-1 (NDM-1): an integrated review of inhibitor development and next-generation therapeutic platforms. [PDF]

RSC Adv
Mohanty A, Sahoo RK, Sanket AS, Rout E.
europepmc   +1 more source

Metallo-beta-lactamase producing Pseudomonas aeruginosa strains isolated in hospitals in Recife, PE, Brazil

, 2017
Out of 24 nosocomial strains of Pseudomonas aeruginosa from Recife, Brazil, 15 (62%) were metallo-beta-lactamase producers. Such isolates were resistant to main antipseudomonas drugs, except polymixyn B and aztreonam.
Magalhaes, Marcelo, Magalhaes, Vera, Lins, Ana Kelly   +2 more
core  

Comparison of laboratory-developed methods for aztreonam plus ceftazidime-avibactam antimicrobial susceptibility testing for metallo-beta-lactamase-producing Enterobacterales. [PDF]

J Clin Microbiol
Bhatnagar AS, Harris H, Jacobs E, Bumpus-White P, Balbuena R, Stambaugh H, Crayton K, Haynie J, Quintero Ilutsik J, Longo C, Bergman Y, Singh S, Murray M, Sabour S, Robinson ML, Machado M-J, Simner PJ.   +16 more
europepmc   +1 more source

Activity of novel antibiotics against dual metallo-Beta-lactamase producing <i>Enterobacter hormaechei</i> clinical isolates. [PDF]

JAC Antimicrob Resist
Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, Peters A, Araos R, García P, Tamma PD, Munita JM.   +10 more
europepmc   +1 more source